ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01589367
Recruitment Status : Recruiting
First Posted : May 1, 2012
Last Update Posted : April 19, 2018
Sponsor:
Information provided by (Responsible Party):
Seoul National University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2018
  Estimated Study Completion Date : October 2018
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):